Processa Pharmaceuticals (PCSA) Amortizatization of Intangibles (2013 - 2019)
Processa Pharmaceuticals' (PCSA) quarterly Amortizatization of Intangibles came in at $18730.0 in Q3 2019, up 2.15% on a QoQ basis from $18335.0 in Q2 2019.
Processa Pharmaceuticals (PCSA) Amortizatization of Intangibles (2013 - 2019) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 5 years of Amortizatization of Intangibles data on file, last reported at $18730.0 in Q3 2019.
- Quarterly Amortizatization of Intangibles changed N/A year-over-year to $18730.0 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $55012.0 (changed N/A YoY) and the FY2016 annual result came in at $967.0, down 98.36% from the prior year.
- Amortizatization of Intangibles improved to $18730.0 in Q3 2019, from $18335.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $18730.0 in Q3 2019 to a low of $967.0 in Q1 2016.
- A 3-year average of $14347.5 and a median of $14821.0 in 2015 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2015 — Amortizatization of Intangibles tumbled 31.24% — and 2016, when it slumped 93.33%.
- Tracing PCSA's Amortizatization of Intangibles over 3 years: stood at $14821.0 in 2015, then sank by 93.48% to $967.0 in 2016, then soared by 1836.92% to $18730.0 in 2019.
- The last three Amortizatization of Intangibles figures came in at $18730.0 (Q3 2019), $18335.0 (Q2 2019), and $17947.0 (Q1 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Processa Pharmaceuticals | 5.69 Mn | 5.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 18,730.00 |
| Sep 30, 2019 | 18,730.00 |
| Jun 30, 2019 | 18,335.00 |
| Jun 30, 2019 | 18,335.00 |
| Mar 31, 2019 | 17,947.00 |
| Mar 31, 2019 | 17,947.00 |
| Mar 31, 2016 | 967.00 |
| Mar 31, 2016 | 967.00 |
| Dec 31, 2015 | 14,821.00 |
| Dec 31, 2015 | 14,821.00 |
| Sep 30, 2015 | 14,821.00 |
| Sep 30, 2015 | 14,821.00 |
| Jun 30, 2015 | 14,660.00 |
| Jun 30, 2015 | 14,660.00 |
| Mar 31, 2015 | 14,499.00 |
| Mar 31, 2015 | 14,499.00 |
| Dec 31, 2014 | 22,916.00 |
| Dec 31, 2014 | 22,916.00 |
| Sep 30, 2014 | 58,344.00 |
| Sep 30, 2014 | 58,344.00 |